IGLV9-49 and COVID-19: In particular, two independent studies revealed significant upregulation of IGKV3-7 in asymptomatic COVID-19 individuals [40] and IGLV9-49 in COVID-19 patients [41] respectively, which implies that these two proteins may be involved in acute lung inflammation.